Janakiram Ajjarapu and ICP Acquire 27.9% Stake in Longevity Health Holdings Amid CEO Appointment

On April 8, 2026, Janakiram Ajjarapu and International Capital Partners LLC (ICP) filed a Schedule 13D reporting a new 27.9% stake in Longevity Health Holdings, Inc. (XAGE). The reporting persons acquired 689,656 shares of Common Stock on March 13, 2026, at a price of $0.29 per share, totaling approximately $200,000.24. This transaction was part of a planned leadership transition; effective March 16, 2026, Mr. Ajjarapu was appointed as the Issuer's CEO, Chairman of the Board, and a Class III director. The filing discloses that Mr. Ajjarapu is currently appealing a July 2025 order from the Securities and Exchange Board of India (SEBI) related to alleged stock manipulation at Decipher Labs Limited. While the SEBI Order initially barred him from securities markets for three years, the Securities Appellate Tribunal has granted partial relief, staying trading restrictions pending appeal. ICP funded the purchase through working capital. The agreement includes registration rights requiring the Issuer to file a resale registration statement within 60 days of the appointment date.